8-K: Axon Enterprise Reports Strong Q1 2026 Results, Raises Outlook
Quarterly Results
Axon Enterprise announced record Q1 2026 revenue of $807 million, a 34% year-over-year increase, driven by robust demand across its product ecosystem and a raised full-year revenue outlook.
Summary
- Axon Enterprise reported record first-quarter 2026 revenue of $807 million, marking a 34% increase year-over-year and its ninth consecutive quarter of over 30% growth.
- Software & Services revenue grew 35% to $355 million, with AI products seeing over 700% growth and counter-drone products up over 300%.
- Net income was $169 million, with non-GAAP net income at $133 million and Adjusted EBITDA at $202 million.
- The company raised its full-year 2026 revenue growth outlook to 30%-32% and maintained its Adjusted EBITDA margin forecast of 25.5%.
- Full-year operating cash flow is expected to exceed $600 million, with free cash flow projected at approximately $450 million.
- New AI-driven products like Axon Vision and Axon Guardian were highlighted, with field trials for Axon Vision targeted for mid-2026.
- Annual recurring revenue reached $1.5 billion, up 35% year-over-year, and net revenue retention was 125%.
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a highly positive filing, with record revenues, raised outlook, and exceptional growth in key AI and counter-drone segments, despite minor gross margin pressures.
Positives
- Record quarterly revenue of $807 million, up 34% year-over-year.
- Strong growth in Software & Services revenue (up 35% to $355 million) and AI products (up over 700%).
- Significant increase in counter-drone product revenue (up over 300%).
- Raised full-year revenue growth outlook to 30%-32% from 27%-30%.
- Maintained full-year Adjusted EBITDA margin guidance of 25.5%.
- Annual recurring revenue grew 35% to $1.5 billion.
- Net revenue retention of 125% indicates strong customer value and expansion.
- Future contracted bookings increased 44% year-over-year to $14.3 billion.
Negatives
- Total company gross margin decreased 150 basis points year-over-year to 59.1%, primarily due to global tariffs and a higher mix from Dedrone, along with increased professional services costs.
- Adjusted gross margin for Connected Devices decreased 240 basis points year-over-year to 50.4%, also impacted by global tariffs and the mix of Dedrone products.
- Operating cash flow was an outflow of $32 million, compared to an inflow of $26 million in the prior year, due to increased inventory investments and higher interest expense.
- Free cash flow was an outflow of $55 million, down from the prior year, though strong positive free cash flow is expected for the full year.
Risks
- Potential for cancellations of government contracts due to non-appropriation clauses or exercise of cancellation clauses.
- Dependence on law enforcement agencies' ability to obtain funding, which can be affected by tax revenues.
- Challenges in designing, introducing, and selling new products, services, or features.
- Risks associated with litigation and protecting intellectual property, including associated costs.
- Ability to win bids through the open bidding process for governmental agencies.
- Supply chain management risks, including production delays, shortages, and impacts on gross margins.
- Impacts of inflation, macroeconomic conditions, and global events.
- Potential for defects in or misuse of products.
Future Outlook
Axon Enterprise raised its full-year 2026 revenue growth outlook to a range of 30% to 32%, an increase from the previous 27% to 30% guidance. The company maintained its full-year Adjusted EBITDA margin expectation of approximately 25.5%. Full-year operating cash flow is projected to exceed $600 million, and free cash flow is expected to be approximately $450 million. Capital expenditures for 2026 are anticipated to be between $160 million and $190 million.
Management Comments
- "Axon entered 2026 with strong momentum, delivering record quarterly revenue and marking our ninth consecutive quarter of 30%+ growth."
- "This performance was driven by robust demand across our ecosystem of products, including TASER 10, Axon Body 4, counter-drone, real-time operations and artificial intelligence (AI)."
- "Underpinning these results is our continued investment in innovation alongside strong, consistent profitability, with first quarter revenue growth of 34%, net income margin of 21% and an Adjusted EBITDA margin of 25%."
- "Our results exceeded expectations and support an increased outlook for the year."
- "Axon's customers are being asked to do more with greater transparency and higher expectations. We are breaking down information barriers and providing a secure, compliant foundation to help prevent harm, accelerate justice and protect life in the communities our customers serve."
Industry Context
StockSavvy.ai notes that Axon's strong performance, particularly in AI and counter-drone technologies, aligns with broader trends in public safety and enterprise security demanding advanced data analysis and threat mitigation capabilities. The company's ability to integrate these new technologies into its existing ecosystem positions it favorably against competitors.
Comparison to Industry Standards
- Axon's revenue growth of 34% in Q1 2026 significantly outpaces the typical growth rates seen in the broader enterprise software and hardware sectors, which often range from single digits to low double digits.
- The 700%+ growth in AI products is exceptional and far exceeds industry benchmarks for AI adoption and revenue generation in specialized verticals.
- The 125% net revenue retention rate is a strong indicator of customer satisfaction and upselling success, generally considered a best-in-class metric for SaaS companies.
- Axon's Adjusted EBITDA margin of 25.0% is robust and competitive within the technology and public safety equipment manufacturing industries, though specific comparisons vary widely by sub-sector.
Stakeholder Impact
- Shareholders: Positive impact from raised revenue outlook, strong financial performance, and continued innovation, potentially leading to increased shareholder value.
- Customers (Public Safety Agencies): Benefit from advanced AI-driven tools and integrated solutions designed to enhance safety, efficiency, and accountability.
- Employees: Continued investment in R&D and product development may lead to new opportunities, while stock-based compensation programs are tied to performance.
- Suppliers: Increased demand for products, particularly in growing segments like counter-drone, may lead to increased orders and partnerships.
Next Steps
- Field trials for Axon Vision are targeted for mid-2026.
- General availability for Axon Vision is expected in early Q4 2026.
- Axon Assistant will expand to additional field devices, including smartwatch integrations later in 2026.
- Continued investment in counter-drone technology to extend leadership position.
- Focus on integrating new product innovations into the connected operating system for public safety.
Key Dates
| Date | Description |
|---|---|
| May 6, 2026 | Date of Report (Date of earliest event reported) |
| March 31, 2026 | End of the first quarter for which financial results are reported. |
| May 6, 2026 | Date of shareholder letter regarding financial results. |
| Mid-2026 | Target for field trials of Axon Vision. |
| Early Q4 2026 | Expected general availability for Axon Vision. |
| Later this year | Expansion of Axon Assistant to additional field devices, including smartwatch integrations. |
Recommendation
strong buyThe filing demonstrates exceptional revenue growth, significant advancements in AI and emerging technologies, and a raised forward-looking outlook. The company's ability to consistently deliver strong results and innovate in critical public safety areas, coupled with robust financial metrics, supports a strong buy recommendation for seasoned investors.
Keywords
Axon Enterprise, 8-K Filing, Q1 2026 Earnings, Public Safety Technology, AI Products, Counter-Drone, TASER, Body Cameras
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.